世衛組織警告:奧密克戎傳播速度前所未見,不要低估其危害性
智通財經APP獲悉,世衛組織警告,世界低估了奧密克戎毒株的危害性,因爲該毒株的傳播速度比以往任何一種新冠毒株都快。
世衛組織總幹事譚德塞表示,目前已經有約77個國家和地區報告檢出奧密克戎毒株。該毒株可能已經蔓延至絕大多數國家,只不過一些國家還未發現而已。
世衛組織高級顧問Bruce Aylward週二表示:“我們擔心人們會草率地得出結論,認爲這只是一種輕微的毒株。”
“一種更具傳染性的病毒與一種更嚴重但傳染性更弱的病毒造成的損害一樣多,甚至更多。”
他補充道,假日期間社交活動增加,再加上更容易傳播的奧密克戎毒株,可能會導致“非常危險的情況”。
南非的研究顯示,儘管新冠疫苗對奧密克戎毒株的有效性降低,但輝瑞(PFE.US)和BioNTech
SE(BNTX.US)以及強生(JNJ.US)生產的疫苗似乎在很大程度上仍可避免重症。 輝瑞疫苗可預防70%的奧密克戎感染者入院。
早期觀察顯示,大多數患者不需要吸氧或強化治療,不過目前正在進行更多研究,以更好地評估奧密克戎的風險。
“當然,我們現在已經認識到,我們低估了這種病毒的危險性,”譚德塞表示。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.